Administration of drugs by nebulizer device [Design Issues]

posted by ElMaestro  – Denmark, 2014-10-17 17:22 (4270 d 19:30 ago) – Posting: # 13743
Views: 3,765

Hello Mauricio,

❝ Is possible to performing a bioequivalence study with a product that the administration is made by a device misting (nebulizer)? How to proceed with to drug ( minim systemic bioavailability) that escapes laterally from the front mask?


❝ Anybody to have an opnion about it?


BE is sometimes used to compare drugs for inhalation. See e.g. the EU guideline. By convention you study the amount of drug in the blood; what escapes at the nozzle/mouthpiece/mask area isn't really of much interest.
Comparative PK is used for both safety and efficacy (the latter often together with charcoal to block GI absorption), and it is a matter that is subject to much debate.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
239 visitors (0 registered, 239 guests [including 17 identified bots]).
Forum time: 12:53 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5